- Home
- BHVN vs RPD Comparison
BHVN vs RPD Comparison
Compare BHVN & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- RPD
- Stock Information
- Founded
- BHVN 2013
- RPD 2000
- Country
- BHVN United States
- RPD United States
- Employees
- BHVN N/A
- RPD N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- RPD Computer Software: Prepackaged Software
- Sector
- BHVN Health Care
- RPD Technology
- Exchange
- BHVN Nasdaq
- RPD Nasdaq
- Market Cap
- BHVN 1.7B
- RPD 1.3B
- IPO Year
- BHVN 2017
- RPD 2015
- Fundamental
- Price
- BHVN $15.63
- RPD $18.40
- Analyst Decision
- BHVN Strong Buy
- RPD Hold
- Analyst Count
- BHVN 14
- RPD 19
- Target Price
- BHVN $49.23
- RPD $27.00
- AVG Volume (30 Days)
- BHVN 2.4M
- RPD 984.8K
- Earning Date
- BHVN 11-11-2025
- RPD 11-05-2025
- Dividend Yield
- BHVN N/A
- RPD N/A
- EPS Growth
- BHVN N/A
- RPD N/A
- EPS
- BHVN N/A
- RPD 0.43
- Revenue
- BHVN N/A
- RPD $855,361,000.00
- Revenue This Year
- BHVN N/A
- RPD $2.75
- Revenue Next Year
- BHVN $2,195.07
- RPD $3.21
- P/E Ratio
- BHVN N/A
- RPD $42.74
- Revenue Growth
- BHVN N/A
- RPD 4.67
- 52 Week Low
- BHVN $12.79
- RPD $17.75
- 52 Week High
- BHVN $55.70
- RPD $44.48
- Technical
- Relative Strength Index (RSI)
- BHVN 51.87
- RPD 33.59
- Support Level
- BHVN $14.32
- RPD $18.56
- Resistance Level
- BHVN $16.24
- RPD $18.81
- Average True Range (ATR)
- BHVN 0.82
- RPD 0.63
- MACD
- BHVN 0.11
- RPD -0.12
- Stochastic Oscillator
- BHVN 60.92
- RPD 6.72
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.